Antiviral Drug Resistance Market to Reach US$ 4,573.24 Mn at a CAGR of 6.8% in 2027 | The Insight Partners

Antiviral Drug Resistance Market to 2027 - Global Analysis and Forecasts By Product (Kits & Reagents and Instruments), Disease Indication (Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV]), Technology (Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], and Other Technologies), End User (Hospitals & Clinics, Pathology or Diagnostic Laboratories and Research Institutes), and Geography

Publication Month: Aug 2019 | Report Code: TIPRE00006395 | No. of Pages: 150 | Category: Biotechnology | Status: Published

The global antiviral drug resistance market expected to be US$ 2,572.26 Mn in 2018 and is predicted to grow at a CAGR of 6.8% during the forecast period 2019 - 2027, to reach US$ 4,573.24 Mn by 2027.

 

Europe is the second largest geographic market and is expected to be the second most significant revenue contributor throughout the forecast period. The region has witnessed several advancements in the field of biotechnology due to increased emphasis on R&D activities in the region. The growth is driven by factors such as increased prevalence of HIV and hepatitis and supportive policies by the government to tackle burden of the diseases.

 

Exhibit: Lucrative Regional Antiviral Drug Resistance Markets


 

Market Insights

Rise in the Incidences of Hepatitis Diseases

Viruses are the tinier germs that can cause several infectious diseases such as flu, common cold, and warts. Viruses can also cause severe illnesses, including smallpox, HIV/AIDS, and Ebola. Viruses reproduce inside cells and able to enter into any living, healthy cells and multiply and produce other viruses like themselves. Different viruses attack specific cells in the body such as liver, brain, skin, blood and also reproductive, respiratory, and gastrointestinal systems.

 

The prevalence of virus infections such as hepatitis has increased during recent years across the globe. Hepatitis causes liver damage and inflammation that can also damage other organs. It is a major global health problem that can cause chronic infection and also upsurge the higher risk of death from cirrhosis and liver cancer. Hepatitis can be categorized as hepatitis A, B, C, D, and E that spread through different causes. According to the WHO (World Health Organization), the prevalence of Hepatitis B is the highest in the African and Western Pacific Region, where 6.1% and 6.2% of the adult population is infected respectively.

 

Increasing Healthcare Expenditures in Emerging Markets

The increasing healthcare expenditure in the emerging economies such as Asia Pacific and South and Central America are enabling the researchers to develop treatment options for a wide range of viral diseases by utilizing advanced techniques such as PCR (Polymerase Chain Reaction), next generation sequencing and others. The viral infectious diseases is anticipated to remain a major public health problem in the coming decades, which poses a threat to both national and international health security. Endemic diseases including, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) will continue to challenge public health. For the early detection and rapid response, high level of awareness is required across the region. Thus, the rapid growth and innovations coming from the emerging nations are expected to increasing the growth opportunities and sales in the global antiviral drug resistance market.

 

Product Insights

The global antiviral drug resistance market by product was led by kits and reagents segment. In 2018, the segment of held the largest market share in the antiviral drug resistance market, by product. The segment is also expected to witness growth at a significant rate during the forecast period since they are an essential requirement for conducting various tests.

 

Exhibit: Antiviral Drug Resistance Market, by Product

 

ANTIVIRAL DRUG RESISTANCE – MARKET SEGMENTATION

 

By Product

  • Kits and Reagents
  • Instruments

 

By Disease Indication

  • Human Immunodeficiency Virus (HIV)
  • Hepatitis
  • Cytomegalovirus (CMV)

 

By Disease Technologies

  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Other Technologies

 

By End User

  • Hospitals & Clinics
  • Pathology or Diagnostic Laboratories
  • Research Institutes

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Siemens AG
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Abbott
  • BD
  • F. Hoffmann-La Roche Ltd.
  • Trinity Biotech

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Antiviral Drug Resistance Market – By Product

1.3.2        Global Antiviral Drug Resistance Market – By Disease Indication

1.3.3        Global Antiviral Drug Resistance Market – By Technology

1.3.4        Global Antiviral Drug Resistance Market – By End User

1.3.5        Global Antiviral Drug Resistance Market – By Geography

2.             Global Antiviral Drug Resistance Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Antiviral Drug Resistance Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

4.3       Expert Opinion

4.4       Cost of Test, By Test Type

4.5       Test Volume, By Region

5.             Global Antiviral Drug Resistance Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Rise in the Incidences of Hepatitis Diseases

5.1.2        Increasing Prevalence of HIV/AIDS

5.2       Key Market Restraints

5.2.1        Alternative Approaches

5.3       Key Market Opportunities

5.3.1        Increasing Healthcare Expenditures in Emerging Markets

5.4       Future Trends

5.4.1        Demand For Higher Quality Products

5.5       Impact Analysis

6.             Antiviral Drug Resistance Market – Global Analysis

6.1       Global Antiviral Drug Resistance Market Revenue Forecasts And Analysis

6.2       Global Antiviral Drug Resistance Market, By Geography - Forecasts And Analysis

6.3       Positioning of Key Players

7.             Global Antiviral Drug Resistance Market Analysis–  by Product

7.1       Overview

7.2       Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)

7.3       Kits and Reagents

7.3.1        Overview

7.3.2        Kits and Reagents Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Instruments

7.4.1        Overview

7.4.2        Instruments Market Revenue and Forecast to 2027 (US$ Mn)

8.             Global Antiviral Drug Resistance Market Analysis–  by Disease Indication

8.1       Overview

8.2       Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)

8.3       HIV

8.3.1        Overview

8.3.2        HIV Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Hepatitis

8.4.1        Overview

8.4.2        Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Cytomegalovirus (CMV)

8.5.1        Overview

8.5.2        Cytomegalovirus (CMV) Market Revenue and Forecast to 2027 (US$ Mn)

9.             Global Antiviral Drug Resistance Market Analysis–  by Technology

9.1       Overview

9.2       Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)

9.3       Immunodiagnostics

9.3.1        Overview

9.3.2        Immunodiagnostics Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Polymerase Chain Reaction (PCR)

9.4.1        Overview

9.4.2        Polymerase Chain Reaction (PCR) Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Next Generation Sequencing (NGS)

9.5.1        Overview

9.5.2        Next Generation Sequencing (NGS) Market Revenue and Forecast to 2027 (US$ Mn)

9.6       Other Technologies

9.6.1        Overview

9.6.2        Other Technologies Market Revenue and Forecast to 2027 (US$ Mn)

10.          Global Antiviral Drug Resistance Market Analysis–  by End User

10.1    Overview

10.2    Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)

10.3    Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals And Clinics Market Revenue and Forecast to 2027 (US$ Mn)

10.4    Pathology and Diagnostic Laboratories

10.4.1     Overview

10.4.2     Pathology and Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.4.3     List of Laboratories, By Region

10.5    Research Institutes

10.5.1     Overview

10.5.2     Research Institutes Market Revenue and Forecast to 2027 (US$ Mn)

11.          Antiviral Drug Resistance Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1    North America Antiviral Drug Resistance Market Revenue And Forecasts To 2027

11.1.1     North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.2     North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.3     North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.1.4     North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.1.5     North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.6     North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

11.1.7     US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.1    US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.2    US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.7.3    US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.1.7.4    US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.1.7.5    US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.8     Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.1    Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.2    Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.8.3    Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.1.8.4    Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.1.8.5    Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.1.9     Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.9.1    Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.9.2    Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.1.9.3    Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.1.9.4    Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.1.9.5    Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2    Europe Antiviral Drug Resistance Market Revenue And Forecasts To 2027

11.2.1     Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.2     Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.3     Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.2.4     Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.5     Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.6     Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

11.2.7     UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.1    UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.7.2    UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.7.3    UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.2.7.4    UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.7.5    UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.8     Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.1    Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.8.2    Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.8.3    Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.2.8.4    Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.8.5    Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.9     France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.1    France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.2    France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.9.3    France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.2.9.4    France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.9.5    France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.10   Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.1 Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.10.2 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.10.3 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.2.10.4 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.10.5 Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.2.11   Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.1 Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.2 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.2.11.3 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.2.11.4 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.2.11.5 Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3    Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027

11.3.1     Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.2     Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.3     Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

11.3.4     Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.3.5     Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.6     Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

11.3.7     Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.7.1    Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.7.2    Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.7.3    Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.3.7.4    Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.3.7.5    Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.8     China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.1    China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.2    China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.8.3    China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.3.8.4    China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.3.8.5    China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.9     India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.9.1    India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.9.2    India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.9.3    India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.3.9.4    India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.3.9.5    India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.10   South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.1 South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.2 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.10.3 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.3.10.4 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.3.10.5 South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.3.11   Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.11.1 Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.3.11.2 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.3.11.3 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.3.11.4 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.3.11.5 Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4    Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts To 2027

11.4.1     Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.2     Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

11.4.3     Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.4.4     Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

11.4.5     Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

11.4.6     Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

11.4.7     UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7.1    UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7.2    UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.7.3    UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.4.7.4    UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.4.7.5    UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.8     Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.8.1    Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.8.2    Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.8.3    Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.4.8.4    Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.4.8.5    Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.4.9     South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.1    South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.2    South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.4.9.3    South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.4.9.4    South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.4.9.5    South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5    South And Central America Antiviral Drug Resistance Market Revenue And Forecasts To 2027

11.5.1     South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.2     South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.3     South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.5.4     South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.5.5     South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5.6     South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027,  By Country (%)

11.5.7     Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.7.1    Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.7.2    Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.7.3    Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.5.7.4    Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.5.7.5    Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.5.8     Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.1    Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.2    Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.5.8.3    Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

11.5.8.4    Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

11.5.8.5    Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12.          Antiviral Drug Resistance Market– Industry Landscape

12.1    Overview

13.          Antiviral Drug Resistance Market–Key Company Profiles

13.1    AccuBioTech Co., Ltd.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Financial Overview

13.1.4     Product Portfolio

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    ACON Laboratories, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Financial Overview

13.2.4     Product Portfolio

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Siemens AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Financial Overview

13.3.4     Product Portfolio

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    bioMérieux SA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Financial Information

13.4.4     Product Portfolio

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Bio-Rad Laboratories, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Financial Information

13.5.4     Product Portfolio

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Danaher

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Financial Overview

13.6.4     Product Portfolio

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Abbott

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Financial Overview

13.7.4     Product Portfolio

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    BD

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Financial Overview

13.8.4     Product Portfolio

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    F. Hoffmann-La Roche Ltd.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Financial Overview

13.9.4     Product Portfolio

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Trinity Biotech

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Financial Overview

13.10.4   Product Portfolio

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


LIST OF TABLES

Table 1.            North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 2.            North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

Table 3.            North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 4.            North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 5.            US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 6.            US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 7.            US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 8.            US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9.            Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 10.         Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 11.         Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 12.         Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.         Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 14.         Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 15.         Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 16.         Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17.         Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 18.         Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 19.         Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 20.         Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21.         UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 22.         UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 23.         UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 24.         UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25.         Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 26.         Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 27.         Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 28.         Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 29.         France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 30.         France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 31.         France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 32.         France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 33.         Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 34.         Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 35.         Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 36.         Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37.         Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 38.         Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 39.         Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 40.         Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 41.         Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 42.         Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 43.         Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 44.         Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 45.         Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 46.         Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 47.         Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 48.         Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49.         China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 50.         China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 51.         China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 52.         China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 53.         India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 54.         India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 55.         India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 56.         India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 57.         South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 58.         South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 59.         South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 60.         South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 61.         Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 62.         Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 63.         Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 64.         Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 65.         Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 66.         Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 67.         Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 68.         Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 69.         UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 70.         UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 71.         UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 72.         UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 73.         Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 74.         Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 75.         Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 76.         Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 77.         South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 78.         South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 79.         South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 80.         South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 81.         South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

Table 82.         South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 83.         South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 84.         South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

Table 85.         Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 86.         Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 87.         Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 88.         Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 89.         Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 90.         Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 91.         Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 92.         Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 93.         Glossary of Terms, Antiviral Drug Resistance Market

 

LIST OF FIGURES

Figure 1.          Antiviral Drug Resistance Market Segmentation

Figure 2.          Antiviral Drug Resistance Segmentation, by Region

Figure 3.          Asia Pacific Antiviral Drug Resistance Market, Revenue (US$ Mn), 2018 & 2027

Figure 4.          Global Antiviral Drug Resistance Market By Product, Market Share (%), 2018

Figure 5.          Global Antiviral Drug Resistance Market By Disease Indication, Market Share (%), 2018

Figure 6.          Global Antiviral Drug Resistance Market By Technology, Market Share (%), 2018

Figure 7.          Global Antiviral Drug Resistance Market By End User, Market Share (%), 2018

Figure 8.          North America : PEST Analysis

Figure 9.          Europe: PEST Analysis

Figure 10.       Asia - Pacific: PEST Analysis

Figure 11.       Middle East & Africa: PEST Analysis

Figure 12.       South & Central America: PEST Analysis

Figure 13.       Antiviral Drug Resistance Market Impact Analysis of Driver and Restraints

Figure 14.       Global Antiviral Drug Resistance Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 15.       Global Antiviral Drug Resistance Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 16.       Prominent Players in the Antiviral Drug Resistance Market

Figure 17.       Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)

Figure 18.       Kits and Reagents Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Instruments Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)

Figure 21.       HIV Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Hepatitis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Cytomegalovirus (CMV) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)

Figure 25.       Immunodiagnostics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Polymerase Chain Reaction (PCR) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Next Generation Sequencing (NGS) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Other Technologies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)

Figure 30.       Hospitals And Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 31.       Pathology And Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32.       RESEARCH INSTITUTES Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 33.       North America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 34.       North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

Figure 36.       US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Europe Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 40.       Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

Figure 42.       UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.       France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.       Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       Asia Pacific Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 48.       Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

Figure 50.       Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52.       India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.       South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.       Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.       Middle East & Africa Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 56.       Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

Figure 58.       UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.       South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61.       South and Central America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 62.       South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 63.       South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)

Figure 64.       Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 65.       Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

The List of Companies

  1. Danaher
  2. Abbott
  3. BD
  4. F. Hoffmann-La Roche Ltd
  5. Trinity Biotech
  6. Seimens AG
  7. bioMérieux SA
  8. Bio-Rad Laboratories, Inc
  9. AccuBioTech Co., Ltd.
  10. ACON Laboratories, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antiviral drug resistance market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global antiviral drug resistance market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.